BRIEF-Theravance Biopharma Says FDA Has Approved An Expanded Indication For Trelegy Ellipta
April 25, 2018 at 08:46 AM EDT
* THERAVANCE BIOPHARMA HIGHLIGHTS APPROVAL OF EXPANDED INDICATION IN THE US FOR ONCE-DAILY TRELEGY ELLIPTA FOR TREATMENT OF COPD PATIENTS
